Search research articles
Contact Us
Filters
Showing results (11-20 of 73) with videos related to
Page
of 8
Sort By:
Alimentary Pharmacology & Therapeutics
|
February 1, 1996
Review article: refractory distal colitis -- explanations and options
M G Griffin, P B Miner
Lancet (London, England)
|
October 1, 1994
Is maintenance therapy effective in Crohn's disease?
N J Greenberger, P B Miner
Biochemical Pharmacology
|
April 1, 1979
Bile flow in response to pharmacologic agents. Hepatic DNA as a reference standard
P B Miner, J M Gaito
Gastroenterology Clinics of North America
|
September 1, 1995
Conventional drug therapy in inflammatory bowel disease
M G Griffin, P B Miner
Gastroenterology
|
July 11, 1990
Long-term use of mesalamine enemas to induce remission in ulcerative colitis
W L Biddle, P B Miner
Gastroenterology
|
July 1, 1991
Exacerbation of ulcerative colitis
D J Hermens, P B Miner
Comprehensive Therapy
|
September 1, 1989
Modern treatment of ulcerative colitis
P B Miner, W L Biddle
Gastroenterology
|
November 1, 1986
Delayed rectal sensation with fecal incontinence. Successful treatment using anorectal manometry
W D Buser, P B Miner
Digestive Diseases and Sciences
|
September 1, 1989
Increased colonic mucosal mast cells associated with severe watery diarrhea and microscopic colitis
C A Baum, P Bhatia, P B Miner
Hepatology (Baltimore, Md.)
|
July 1, 1983
Spironolactone- and canrenone-induced changes in hepatic (Na+,K+)ATPase activity, surface membrane cholesterol and phospholipid, and fluorescence polarization in the rat
P B Miner, M Sneller, S S Crawford
Page
of 8
Search research articles
Search
Showing results (11-20 of 73) with videos related to
Sort By:
Page
of 8
Alimentary Pharmacology & Therapeutics
|
February 1, 1996
Review article: refractory distal colitis -- explanations and options
M G Griffin, P B Miner
Lancet (London, England)
|
October 1, 1994
Is maintenance therapy effective in Crohn's disease?
N J Greenberger, P B Miner
Biochemical Pharmacology
|
April 1, 1979
Bile flow in response to pharmacologic agents. Hepatic DNA as a reference standard
P B Miner, J M Gaito
Gastroenterology Clinics of North America
|
September 1, 1995
Conventional drug therapy in inflammatory bowel disease
M G Griffin, P B Miner
Gastroenterology
|
July 11, 1990
Long-term use of mesalamine enemas to induce remission in ulcerative colitis
W L Biddle, P B Miner
Gastroenterology
|
July 1, 1991
Exacerbation of ulcerative colitis
D J Hermens, P B Miner
Comprehensive Therapy
|
September 1, 1989
Modern treatment of ulcerative colitis
P B Miner, W L Biddle
Gastroenterology
|
November 1, 1986
Delayed rectal sensation with fecal incontinence. Successful treatment using anorectal manometry
W D Buser, P B Miner
Digestive Diseases and Sciences
|
September 1, 1989
Increased colonic mucosal mast cells associated with severe watery diarrhea and microscopic colitis
C A Baum, P Bhatia, P B Miner
Hepatology (Baltimore, Md.)
|
July 1, 1983
Spironolactone- and canrenone-induced changes in hepatic (Na+,K+)ATPase activity, surface membrane cholesterol and phospholipid, and fluorescence polarization in the rat
P B Miner, M Sneller, S S Crawford
Page
of 8